Publications database

Displaying 1 - 10 of 83

Financing drug policy in Europe in the wake of the economic recession

The economic crisis that Europe experienced in 2008 and later presented a grave challenge to public finances. Countries responded to this by undertaking fiscal consolidation. By examining public expenditure in the areas...

Drugnet Europe 88

In this issue: Lisbon Addictions 2015: call for abstracts | Best practice: from guidelines to quality standards | Financing drug policy in Europe in the wake of the economic recession | Preventing...

National report 2013: Albania

This report has been produced by a national working group within the European Union financed EMCDDA-IPA project, 'Preparation of IPA Beneficiaries for their participation with the EMCDDA'. It describes the overall picture...

National report 2014: Kosovo *

This report has been produced by a national working group within the European Union financed EMCDDA-IPA project, 'Preparation of IPA Beneficiaries for their participation with the EMCDDA'. It describes the overall picture...

National report 2014: Serbia

This report has been produced by a national working group within the European Union financed EMCDDA-IPA project, 'Preparation of IPA Beneficiaries for their participation with the EMCDDA'. It describes the overall picture...

Pregnancy and opioid use: strategies for treatment

Illicit opioid consumption during pregnancy brings with it the risk of an increase in obstetric complications for the mother and a range of potential dangers for the child, both before and after...

Risk Assessment Report of a new psychoactive substance: 1-cyclohexyl-4-(1,2-diphenylethyl)piperazine (MT-45)

This report presents the data and findings of the risk assessment on the new psychoactive substance, MT-45, that was conducted by the Scientific Committee of the EMCDDA. Concerns over the availability and...

Computer-assisted and online data collection in general population surveys

The aim of the present report is to collect information from a literature review on computer-assisted interviewing and online data collection in general population surveys. It evaluates the pros and cons of...

Drugnet Europe 87

In this issue: EMCDDA scientific paper award 2014 | New report examines residential treatment for drug use in Europe | Exploring therapeutic communities for treating addictions | First European conference on addictive...

EMCDDA–Europol Joint Report on a new psychoactive substance: 1-cyclohexyl-4-(1,2-diphenylethyl)piperazine (‘MT-45’)

In April 2014, the EMCDDA and Europol examined the available information on a new psychoactive substance 1-cyclohexyl-4-(1,2-diphenylethyl)piperazine, commonly known as MT-45. The two organisations concluded that sufficient information had been accumulated to...